Detalhe da pesquisa
1.
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients.
Health Qual Life Outcomes
; 9: 46, 2011 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689425
2.
Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung Cancer.
J Oncol Pract
; 15(11): e948-e956, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31513478
3.
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy.
Lung Cancer
; 119: 112-119, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656745
4.
Assessment of costs associated with adverse events in patients with cancer.
PLoS One
; 13(4): e0196007, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29652926
5.
Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review.
Arch Dermatol Res
; 310(6): 505-513, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29737404
6.
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study.
Eur J Dermatol
; 28(6): 775-783, 2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698147
7.
Differences in Health Care Use and Costs Among Patients With Cancer Receiving Intravenous Chemotherapy in Physician Offices Versus in Hospital Outpatient Settings.
J Oncol Pract
; 13(1): e37-e46, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27845870
8.
Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
Cancer Med
; 4(8): 1205-13, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25991583
9.
Comparative healthcare costs in patients with metastatic melanoma in the USA.
Melanoma Res
; 25(4): 312-20, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882026
10.
Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires.
JAMA Dermatol
; 150(2): 169-76, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24285085
11.
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.
Breast
; 23(6): 763-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25193423
12.
Age distribution of patients with advanced non-melanoma skin cancer in the United States.
Arch Dermatol Res
; 305(9): 845-50, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23604961
13.
Adverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 12(3): 204-213.e1, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276520
14.
Survival outcomes of bevacizumab beyond progression in metastatic colorectal cancer patients treated in US community oncology.
Clin Colorectal Cancer
; 11(4): 238-46, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658457
15.
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer.
BMC Res Notes
; 5: 314, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22716038
16.
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.
J Med Econ
; 14(5): 542-52, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21728912